Solutions

Wir haben für alles eine Lösung – und die entsprechende Erfahrung. In unseren derzeit sieben Kompetenzbereichen stehen wir Ihnen mit unserem umfassenden Know-how mit Rat und Tat zur Seite.

Alle Solutions

Willkommen in unserem virtuellen Showroom!

In unserem virtuellen Showroom präsentieren wir Ihnen unser umfangreiches Portfolio und Innovationen – rund um die Uhr!

Software

Software

Mit unseren Werum PAS-X Softwarelösungen sind wir weltweit führender Anbieter und Partner für die Pharma-, Biotech- und Zell- und Gentherapie-Industrie. Durch unsere PAS-X MES Suite und weitere intelligente Produkte und Services erschließen Sie das volle Potenzial ihrer Wertschöpfungsketten.

Übersicht Software

Transportsysteme

Transportsysteme

Wir sind Spezialisten für komplette Transportsysteme im Bereich Pharma- und Medizinprodukte. Unsere Lösungen sind maßgebend im Bereich des kontaktlosen und sicheren Transports von z.B. Glasspritzen.

Übersicht Transportsysteme

Inspektion

Inspektion

Als weltweit führender Inspektionsexperte entwicklen wir Lösungen für die Pharma und Biotechindustrie. Unser Angebot reicht von Hochleistungsmaschinen und Halbautomaten über Laboreinheiten bis Inspektionsapplikationen für die Inprozesskontrolle.

Übersicht Inspektion

Maschinen-Finder

Verpackungsmaterial

Verpackungsmaterial

Als langjährige Spezialisten entwickeln wir Verpackungslösungen für innovative und hochwertige Pharma-Sekundärverpackungen aus Karton. Wir bieten Ihnen Lösungen für Fälschungssicherheit, Standard- Faltschachteln und vieles mehr.

Übersicht Verpackungsmaterial

Services

Sie benötigen Hilfe bei einem bestimmten Produkt oder haben Fragen zu einem unserer Kompetenzbereiche? Nutzen Sie unser umfangreiches Serviceangebot, wir unterstützen Sie schnell und unkompliziert.

Alle Services

Transportsysteme

Transportsysteme

Wir sind Spezialisten für komplette Transportsysteme im Bereich Pharma- und Medizinprodukte. Unsere Lösungen sind maßgebend im Bereich des kontaktlosen und sicheren Transports von z.B. Glasspritzen.

Übersicht Transportsysteme Services

Inspektion

Inspektion

Wir bieten unseren Kunden vielfältige Inspektionslösungen und Qualitätskontrollen auf höchstem Niveau. Erfahren Sie mehr über die passende Technologie für Ihre Anforderungen.

Übersicht Inspektion Services

Verpackungsmaschinen

Verpackungsmaschinen

Unsere Verpackungsmaschinen sichern Ihnen maximale Flexibilität und Produktivität für Ihre Verpackungsprozesse. Erfahren Sie mehr über unsere modularen, kundenspezifischen Verpackungslösungen.

Übersicht Verpackungsmaschinen Services

Support whenever and whereever you need it. Reduce your downtime and improve your production quality with Körber Xpert View.

Verpackungsmaterial

Verpackungsmaterial

Die Anforderungen an Arzneimittelverpackungen sind hoch: Fälschungs- und kindersicher sollen sie sein, aber auch kompakt und nachhaltig. Erfahren Sie hier, wie wir Verpackungen zukunftssicher machen.

Übersicht Verpackungsmaterial Services

Über uns

Wir von Körber im Geschäftsfeld Pharma sind der Ansprechpartner, wenn es um pharmazeutische Produkte geht. Als führender Systemanbieter beraten wir unsere Kunden von der Entwicklung über die Herstellung bis zur Inspektion und Verpackung ihrer Produkte.

Alles über uns

Mediacenter

Mediacenter

In unserem Mediacenter finden Sie alle Inhalte rund um unsere Webinare, Produkt- und Markeninformationen wie Downloads, Videos und dem Virtuelen Showroom gesammelt an einem Ort.

Alle Medienangebote

Referenzen

Referenzen

Sie möchten wissen, wie wir unterschiedliche Kundenanforderungen nachhaltig und effizient gelöst haben? 
Was Projektpartner über uns sagen oder mit welchen Branchenauszeichnungen unsere Innovationen ausgezeichnet wurden? 

Lukas Marschall

Blog

What is a (qualified) bioprocess scale down model?

Highlights

  • What is a bioprocess scale down model;
  • Regulatory guidance about scale down models;
  • Pitfalls in developing scale-down models;
  • Best practices to qualify scale-down models.

You develop, optimize and characterize bioprocesses in laboratory scale. Yet, you expect that the insights from laboratory scale do not change during scale-up. Hence, your laboratory results are representative and predictive for the final manufacturing scale. To ensure that, you need a robust and predictive bioprocess scale-down model. Therefore, developing the bioprocess scale-down model is the core of your development and validation activities.

What is a bioprocess scale-down model? 

ICH and FDA process validation guidelines provide definitions for bioprocess scale-down models.  ICH Q11 states that a scale-down model is a representation of the commercial process. You have to justify the predictive power of your scale down model:

If you want to learn how to perform a successful process characterization study and what steps need to be taken, visit this blog post

„A scale-down model is a representation of the proposed commercial process“ ICH Q11, Step 4
“Small-scale models can be developed and used to support process development studies. The development of a model should account for scale effects and be representative of the proposed commercial process. A scientifically justified model can enable a prediction of quality, and can be used to support the extrapolation of operating conditions across multiple scales and equipment.” ICH Q11 Step 4
 “It is important to understand the degree to which models represent the commercial process, including any differences that might exist, as this may have an impact on the relevance of information derived from the models.” FDA 2011 Process Validation Guideline

 
Available guidance points out:

  • You need to understand the differences between your scale-down model and the commercial process.
  • You have to make proper use of the knowledge gained from scale-down models. 

Authorities point out the importance of scale-down models. However, authorities provide no specific information on how to develop “compliant” scale-down models.

Why is a “predictive” bioprocess scale-down model so important? 

A non-predictive bioprocess scale down model has severe consequences:

  • The management cost of goods sold (COGs) estimations is incorrect. 
  • Your bioprocess in manufacturing scale runs will run at suboptimal conditions. 
  • Your drug product quality attributes might change during scale-up. Hence, for a biosimilar process, you might lose your product bioequivalence during scale-up.
  • Regulatory bodies review the scale-down model for process validation stage 1. As a result, your validation campaign is at risk.

What can go wrong in designing a bioprocess scale-down model?

But how to justify that your scale-down model is predictive? To do that, you have to understand what can go wrong. In process optimization and process characterization studies, you investigate the influence of potential critical process parameters (pCPPs) on your product quality (critical quality attributes, CQAs). You expect the same effects in small and large scales. However, this might not be the case due to scale-up effects. Figure 1 shows what can go wrong.

Figure 1, plot A: A perfect predictability of your scale-down model means that the same effect that you observe on a small scale (blue trend) exists on a large scale (red trend).; Figure 1, plot B: At target process conditions, you observe an offset between your scale-down model and your commercial process. However, your effects still point in the same direction.
Figure 1, plot C: At target process conditions, you observe no offset. However, your effects are different on a large and small scale. Hence, your scale-down model is non-predictive.; Figure 1, plot D: At target process conditions, you observe an offset, and your effects are different on a large and small scale. Hence, your scale-down model is non-predictive.

As a bioprocess scientist dealing with scale-down models, you have to find out for each critical quality attribute (CQA) whether your scale-down model is case A (predictive), B (semi-predictive), or C and D (not predictive). 

Case A is desired as your scale-down model behaves similar to the manufacturing scale process. Therefore, your knowledge gained on a small scale is directly transferable to the manufacturing scale. For case B, an offset in a certain quality attribute can still be accepted if the functional behavior of this quality attribute stays similar across scales. Case C and case D are undesirable.

As manufacturing scale experiments are expensive, a commonly agreed-upon methodology for scale-down model qualification is to qualify the model on set-point conditions. With this approach, you rule out case B and case D. However, if you prove similarity on target, you still do not know whether your effects are similar (case A) or different (case C) across scales. So, case C represents the worst-case scenario, as common statistical methods cannot rule it out. Looking at it theoretically, it is less improbable that different effects (straight lines with different slopes) intersect at target (case C) than they intersect anywhere else (case D). Therefore, different effects (case B) are less likely than similar effects (case A) at similar target behavior. However, to gain absolute assurance, you need to perform large-scale experiments on other than target conditions.

Though, as discussed above, case B might still be acceptable, but regarding the patients' risk, it is better to reject similarity of your scale-down model rather too much than too little.

Best practices to establish bioprocess scale-down models

Best practices for qualification scale-down models are based on the combination of statistical tools (equivalence testing), multivariate data analysis, and risk assessments. Here are the main messages:

  • Explore multivariate differences between small and commercial scales by multivariate data analysis.
  • Use equivalence testing & time series equivalence testing to demonstrate the quality of your scale-down model. 
  • Use a risk-based approach and simulations to deal with the risk of offsets.
  • Implement the results to assess the overall criticality of the process parameters.
Figure 2: Illustration of the best-practice workflow for scale-down model qualification.

Software to support scale-down model development

Werum PAS-X Savvy is a bioprocess data management and data analytics software. Leading biotech companies use Werum PAS-X Savvy for bioprocess development, characterization, and scale-down model development and qualification. 
 

Kommentare

Keine Kommentare

Kommentar schreiben

* Diese Felder sind erforderlich

nach oben
nach oben